3′-Deoxy-3′-18F-fluorothymidine positron emission tomography as an early predictor of disease progression in patients with advanced and metastatic pancreatic cancer
Crossref DOI link: https://doi.org/10.1007/s00259-015-3000-2
Published Online: 2015-02-12
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Challapalli, Amarnath
Barwick, Tara
Pearson, Rachel A.
Merchant, Shairoz
Mauri, Francesco
Howell, Elizabeth C.
Sumpter, Katherine
Maxwell, Ross J.
Aboagye, Eric O.
Sharma, Rohini
Text and Data Mining valid from 2015-02-12